Previous Close | 8.47 |
1-Year Change | 93.82% |
6-Months Change | 24.19% |
3-Months Change | 3.93% |
Moving Avg (50d) | 8.5776 |
Moving Avg (200d) | 7.0725 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 2.62B |
Beta (3-Years) | 1.15 |
Revenue Growth (ttm) | 12.32% |
Net Profit Margin (ttm) | -6.71% |
Return On Assets (ttm) | -5.19% |
EPS (ttm) | -0.85 |
PE Ratio (ttm) | -9.96 |
Dividend Yield | % |
Asset Description: | Amneal Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-14 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
8.578 | 8.83 | 8.999 | 9.251 | 9.671 | 10.092 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |